Optimising early-stage drug development with continuous processing
Manufacturing Chemist, 30 April 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Manufacturing Chemist, 30 April 2025
Scientist Live, 12 May 2025
Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Carcinoma - the third leading cause of cancer-related deaths worldwide
News release, 29 April 2025
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
The Medicine Maker, 13 February 2026
The certification is granted to Hovione's four manufacturing sites for the third consecutive year.
Hovione has once again solidified its position as a top employer.